The risk of deep venous thrombosis with oral contraceptives containing drospirenone

@article{Dunn2011TheRO,
  title={The risk of deep venous thrombosis with oral contraceptives containing drospirenone},
  author={N. Dunn},
  journal={BMJ : British Medical Journal},
  year={2011},
  volume={342}
}
  • N. Dunn
  • Published 2011
  • Medicine
  • BMJ : British Medical Journal
    • Data are inconclusive, but alternatives may be preferable unless specifically contraindicated 
    View on BMJ
    ncbi.nlm.nih.gov
    12 Citations
    Background Citations
    2
    Results Citations
    1
    12 Citations
    Citation Type

    Citation Type

    Is an EMA review on hormonal contraception and thrombosis needed?
    • 6
    Estrogen and thrombosis: Controversies and common sense
    • T. Deloughery
    • Medicine
    • Reviews in Endocrine and Metabolic Disorders
    • 2011
    • 12
    Oral contraceptives and venous thromboembolism: pill scares and public health.
    • R. Reid
    • Medicine
    • Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
    • 2011
    • 12
    Angiotensin receptor blockers and cardiovascular outcomes
    • F. Hobbs
    • Medicine
    • BMJ : British Medical Journal
    • 2011
    • 1
    Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases
    • 130
    • PDF
    PCOS in Adolescence: Diagnostic Dilemmas and Management Considerations
    Pulmonary embolism in a female collegiate cross-country runner presenting as nonspecific back pain.
    • 8
    Use of oral contraceptives in three European countries: a population-based multi-database study
    • I. Bezemer, K. Verhamme, +6 authors R. Herings
    • Medicine
    • The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
    • 2016
    • 13
    Simultaneous analysis and Validation of Risperidone and Drospirenone drugs in Pharmaceutical dosage form
    • 3
    Control of endothelin-a receptor expression by progesterone is enhanced by synergy with Gata2.
    • 12
    • PDF

    References

    SHOWING 1-10 OF 10 REFERENCES
    Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate
    • 46
    • Highly Influential
    Risk of Thromboembolism in Women Taking Ethinylestradiol/Drospirenone and Other Oral Contraceptives
    • 124
    The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study
    • 376
    • PDF
    Hormonal contraception and risk of venous thromboembolism: national follow-up study
    • 431
    • PDF
    Combined oral contraceptive pills for treatment of acne.
    • 95
    The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.
    • 367
    Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database
    • 155
    • PDF
    Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data
    • 170
    • PDF
    The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study
    • 181
    The venous thrombotic risk of oral contraceptives , effects of oestrogen dose and progestogen type : results of the MEGA study
    • BMJ
    • 2009